Oncosite - Centro de Pesquisa Clinica Em Oncologia Ltda
Ijui, RS, Brazil
Pesquisa e desenvolvimento de produtos em Ijuí, Rio Grande do Sul
About Oncosite - Centro de Pesquisa Clinica Em Oncologia Ltda
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
7
Janssen Research & Development, LLC
5
Merck Sharp & Dohme LLC
2
NovoCure Ltd.
1
PharmaMar
1
Clinical Trials at Oncosite - Centro de Pesquisa Clinica Em Oncologia Ltda
During the past decade, Oncosite - Centro de Pesquisa Clinica Em Oncologia Ltda conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel (PANOVA-3)
A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer
A Study Evaluating the Safety and Efficacy of Cobimetinib Plus Atezolizumab in BRAFV600 Wild-type Melanoma With Central Nervous System Metastases and Cobimetinib Plus Atezolizumab and Vemurafenib in BRAFV600 Mutation-positive Melanoma With Central Nervous System Metastases
Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756)
A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer
A Study of Tiragolumab in Combination With Atezolizumab Compared With Placebo in Combination With Atezolizumab in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1-Selected Non-Small Cell Lung Cancer
2020-03-04
2025-02-21
Recruiting
660
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Oncosite - Centro de Pesquisa Clinica Em Oncologia Ltda" #1 sponsor was "Hoffmann-La Roche" with 7 trials, followed by "Janssen Research & Development, LLC" with 5 trials
sponsored, "Merck Sharp & Dohme LLC" with 2 trials sponsored, "NovoCure Ltd." with 1 trials sponsored and "PharmaMar"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Oncosite - Centro de Pesquisa Clinica Em Oncologia Ltda"
#1 collaborator was "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Frontier Science & Technology Research Foundation, Inc." with 1 trials as a collaborator and "Institut Jules Bordet/Clinical Trials Support Unit (IJB/CTSU)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Oncosite - Centro de Pesquisa Clinica Em Oncologia Ltda
According to Clinical.Site data, the most researched conditions in "Oncosite - Centro de Pesquisa Clinica Em Oncologia Ltda" are
"Breast Cancer" (2 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials), "Advanced or Metastatic Esophageal Squamous Cell Carcinoma" (1 trials), "Castration-Resistant Prostatic Cancer" (1 trials) and "Lung Neoplasms" (1 trials). Many other conditions were trialed in "Oncosite - Centro de Pesquisa Clinica Em Oncologia Ltda" in a lesser frequency.
Clinical Trials Intervention Types at Oncosite - Centro de Pesquisa Clinica Em Oncologia Ltda
Most popular intervention types in "Oncosite - Centro de Pesquisa Clinica Em Oncologia Ltda" are "Drug" (14 trials), "Biological" (2 trials), "Device" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (6 trials), "Placebo" (4 trials), "Amivantamab" (2 trials), "Tiragolumab" (2 trials) and "Abiraterone Acetate" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Oncosite - Centro de Pesquisa Clinica Em Oncologia Ltda
The vast majority of trials in "Oncosite - Centro de Pesquisa Clinica Em Oncologia Ltda" are
13 trials for "All" genders and 3 trials for "Male" genders.
Clinical Trials Status at Oncosite - Centro de Pesquisa Clinica Em Oncologia Ltda
Currently, there are NaN active trials in "Oncosite - Centro de Pesquisa Clinica Em Oncologia Ltda".
undefined are not yet recruiting,
7 are recruiting,
8 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Oncosite - Centro de Pesquisa Clinica Em Oncologia Ltda,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Oncosite - Centro de Pesquisa Clinica Em Oncologia Ltda, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 12 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".
Departments of Oncosite - Centro de Pesquisa Clinica Em Oncologia Ltda
Oncosite - Centro de Pesquisa Clinica Em Oncologia Ltda has several departments that took part in Clinical trials: "Oncosite - Centro de Pesquisa Clinica Em Oncologia" - 2 trials